Curemark
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
800 Westchester Ave Ste S528, Rye Brook,...Phone Number
(914) 824-9700Website
www.curemark.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Curemark
Galenagen is a wholly-owned subsidiary of Curemark, LLC, a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Galenagen LLC is focused on antibacterial and antiviral treatments as well as medical devices. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of autism, ADHD, addiction, schizophrenia and Parkinson's disease.Explore more
Curemark Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curemark your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Curemark
Click to see if Curemark had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Curemark has recently received funding, and reach out quickly before it becomes old news!
Curemark, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Curemark is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Curemark recently announced quarterly report
Funding: Get notified immidiatlly once Curemark has new funding data
Product Launch: Get notified when Curemark launches new products
Recommended Actions
Find VP level buyers at Curemark
Find more new buyers
Compare Similar Companies to Curemark
Compare insights from companies similar to Curemark, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Curemark is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Curemark is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curemark.
Curemark financials insights
Gather financial insights about Curemark, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$6M
2013
Private Equity
$18.5M
2014
Debt
$5M
2015
Private Equity
$20.3M
2017
Private Equity
$3M
2018
Private Equity
$3.2M
2020
Debt
$150K
Curemark Tech Stack
A closer look at the technologies used by Curemark
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Board of Directors
New Hire
Executive Move
New Hire
Executive Move
Executive Moves, New Hire
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curemark
Sign Up For FreeTo access detailed company insights
Galenagen is a wholly-owned subsidiary of Curemark, LLC, a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Galenagen LLC is focused on antibacterial and antiviral treatments as well as medical devices. Curemark's pipeline includes preclinical and clinical-stage programs for... Read More
